{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease (PD), specifically associated with PARK8.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines LRRK2's role in PD through kinase activity and substrate interaction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assays and pull-down assays were used to assess phosphorylation and interaction with Akt1.",
          "judgment": "Yes",
          "reasoning": "These assays model the proposed pathogenesis involving disrupted kinase activity leading to neurodegeneration."
        },
        {
          "step_name": "Step 3a: Basic controls/replicates",
          "extracted_paper_info": "No explicit mention of basic controls or replicates in the provided sections.",
          "judgment": "No",
          "reasoning": "Insufficient information to confirm basic controls or experimental replicates."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "In vitro kinase assays are a standard technique in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted historically, validating its use."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "No statistical analyses or p-values were mentioned for these variants.",
          "judgment": "No",
          "reasoning": "Insufficient statistical data to calculate OddsPath."
        },
        {
          "step_name": "Step 4b: Number of controls used",
          "extracted_paper_info": "At least three variants (R1441C, G2019S, I2020T) were tested, but the exact number of benign/pathogenic controls isn't specified.",
          "judgment": "Supporting",
          "reasoning": "Assumed to have fewer than 11 control variants, leading to supporting evidence."
        }
      ],
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is causal for autosomal-dominant familial Parkinson’s disease (PD), specifically associated with PARK8.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assays and pull-down assays were used to assess phosphorylation and interaction with Akt1.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls/replicates",
          "extracted_paper_info": "No explicit mention of basic controls or replicates in the provided sections.",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "In vitro kinase assays are a standard technique in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "No statistical analyses or p-values were mentioned for these variants.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4b: Number of controls used",
          "extracted_paper_info": "At least three variants (R1441C, G2019S, I2020T) were tested, but the exact number of benign/pathogenic controls isn't specified.",
          "judgment": "Supporting"
        }
      ],
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is causal for autosomal-dominant familial Parkinson’s disease (PD), specifically associated with PARK8.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assays and pull-down assays were used to assess phosphorylation and interaction with Akt1.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls/replicates",
          "extracted_paper_info": "No explicit mention of basic controls or replicates in the provided sections.",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "In vitro kinase assays are a standard technique in the field.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "No statistical analyses or p-values were mentioned for these variants.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4b: Number of controls used",
          "extracted_paper_info": "At least three variants (R1441C, G2019S, I2020T) were tested, but the exact number of benign/pathogenic controls isn't specified.",
          "judgment": "Supporting"
        }
      ],
      "evidence_strength": "PS3_supporting"
    }
  ]
}